Fleury S.A. (BVMF:FLRY3)
18.28
+0.23 (1.27%)
Aug 19, 2026, 5:04 PM GMT-3
Fleury Revenue
Fleury had revenue of 2.32B BRL in the quarter ending June 30, 2026, with 14.43% growth. This brings the company's revenue in the last twelve months to 8.79B, up 12.11% year-over-year. In the year 2025, Fleury had annual revenue of 8.29B with 7.89% growth.
Revenue (ttm)
8.79B
Revenue Growth
+12.11%
P/S Ratio
1.12
Revenue / Employee
303.15K
Employees
29,000
Market Cap
9.81B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 8.29B | 606.52M | 7.89% |
| Dec 31, 2024 | 7.68B | 1.21B | 18.76% |
| Dec 31, 2023 | 6.47B | 2.01B | 44.99% |
| Dec 31, 2022 | 4.46B | 590.39M | 15.25% |
| Dec 31, 2021 | 3.87B | 901.04M | 30.32% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Rede D'Or São Luiz | 57.79B |
| Raia Drogasil | 46.53B |
| Empreendimentos Pague Menos | 15.64B |
| Bradsaúde | 10.04B |
| Diagnósticos da América | 9.32B |
| Hypera | 8.82B |
| Dimed S.A. Distribuidora de Medicamentos | 5.90B |
| Oncoclínicas do Brasil Serviços Médicos | 4.57B |
Fleury News
- 12 days ago - Fleury Earnings Call Transcript: Q2 2026 - Transcripts
- 12 days ago - Fleury Document: Q2 2026 - Filings
- 12 days ago - Fleury Earnings release: Q2 2026 - Filings
- 12 days ago - Fleury Slides: Q2 2026 - Filings
- 3 months ago - Fleury Earnings Call Transcript: Q1 2026 - Transcripts
- 3 months ago - Fleury Slides: Q1 2026 - Filings
- 3 months ago - Fleury Earnings release: Q1 2026 - Filings
- 3 months ago - Fleury Document: Q1 2026 - Filings